Zoetis, Inc.(NYSE : ZTS)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.85%||180.99||0.7%||$1263.76m|
|BMY||Bristol-Myers Squibb Co.||-1.86%||76.15||1.0%||$1200.63m|
|MRK||Merck & Co., Inc.||0.77%||93.02||0.7%||$1171.65m|
|LLY||Eli Lilly & Co.||3.15%||323.34||1.1%||$1017.85m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||0.15%||143.40||0.0%||$499.78m|
|SIGA||SIGA Technologies, Inc.||41.91%||13.68||0.0%||$209.92m|
|HZNP||Horizon Therapeutics Plc||4.69%||94.84||5.4%||$209.26m|
|NVO||Novo Nordisk A/S||1.07%||107.74||0.1%||$184.03m|
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests, and precision livestock farming technology. The firm operates through the following segments: United States & International. Its products include vaccines, parasiticides, anti-infectives, dermatology products, medicated feed additives, animal health diagnostics, and other pharmaceutical products for both companion animal and livestock customers. The company was founded in 1952 and is headquartered in Parsippany, NJ.